Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467837) titled 'Prevention of Stretch Marks in Expectant Mothers' on March 2.

Study Type: Observational [Patient Registry]

Primary Sponsor: Stratpharma AG

Condition: Pregnant Women Stretch Mark

Intervention: Device: Stratamark

Recruitment Status: Recruiting

Date of First Enrollment: February 24, 2026

Target Sample Size: 10000

Countries of Recruitment: Australia

To know more, visit https://clinicaltrials.gov/study/NCT07467837

Published by HT Digital Content Services with permission from Health Daily Digest....